HeartBeam (BEATW) Amortization of Deferred Charges (2021)

HeartBeam (BEATW) reported Amortization of Deferred Charges of $45000.0 for Q4 2021, down 47.67% quarter-over-quarter from $86000.0 in Q3 2021.

HeartBeam (BEATW) Amortization of Deferred Charges (2021) Analysis & Trends

HeartBeam (BEATW) has 1 years of Amortization of Deferred Charges data on file, last reported at $45000.0 in Q4 2021.

Amortization of Deferred Charges for Q4 2021 came in at $45000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was $45000.0 (down 80.69% YoY), and the FY2021 annual result was $278000.0, up 892.86% from the prior year.
Amortization of Deferred Charges retreated to $45000.0 in Q4 2021 per BEATW's latest filing, from $86000.0 in the prior quarter.
Over five years, Amortization of Deferred Charges peaked at $86000.0 in Q3 2021 and troughed at $45000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	26.11 Bn	18.79 Bn	662.02 Mn
2	BrightSpring Health Services	12.95 Bn	12.07 Bn	482.22 Mn
3	Healthequity	7.46 Bn	7.19 Bn	256.31 Mn
4	Hinge Health	5.15 Bn	4.83 Bn	154.23 Mn
5	Doximity	3.75 Bn	3.00 Bn	125.97 Mn
6	10x Genomics	3.69 Bn	3.15 Bn	106.18 Mn
7	Waystar Holding	3.61 Bn	3.45 Bn	268.04 Mn
8	Privia Health	2.90 Bn	2.54 Bn	595.71 Mn
9	Omnicell	1.72 Bn	1.54 Bn	140.36 Mn
10	HeartBeam	-	-	-

Download Data